Matches in Wikidata for { <http://www.wikidata.org/entity/Q91909125> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q91909125 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91909125 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91909125 description "scientific article published on 01 April 2019" @default.
- Q91909125 description "wetenschappelijk artikel" @default.
- Q91909125 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q91909125 name "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 name "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 type Item @default.
- Q91909125 label "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 label "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 prefLabel "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 prefLabel "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 P1433 Q91909125-B1490520-AC14-4B98-A843-A1EB5812FD5B @default.
- Q91909125 P1476 Q91909125-7788BD0F-6178-4A74-98A6-657E24E32AA5 @default.
- Q91909125 P275 Q91909125-ff5e42cc-3d94-4ee5-aa31-7a25abea4dfe @default.
- Q91909125 P2860 Q91909125-148B6757-27F2-4F8F-BDCC-9D79BD2DA9A1 @default.
- Q91909125 P2860 Q91909125-16269E3C-8556-4A45-AFAE-8A54F3766007 @default.
- Q91909125 P2860 Q91909125-302E5F45-CC45-40D6-AB08-9EDFF9EBE121 @default.
- Q91909125 P2860 Q91909125-358C3B7D-C744-4232-8E37-1EA010981826 @default.
- Q91909125 P2860 Q91909125-3664E4D6-1E85-4FAF-9D08-1208923E8F15 @default.
- Q91909125 P2860 Q91909125-79A245B7-C193-40AF-825B-58CEF56C5768 @default.
- Q91909125 P2860 Q91909125-A0002EB5-B75B-412D-A04F-4494BC1E40CE @default.
- Q91909125 P2860 Q91909125-BB242D7F-A755-4FE7-992C-880F02B8FFD8 @default.
- Q91909125 P2860 Q91909125-C88B4A30-42DA-4B0F-91C6-64D319746B49 @default.
- Q91909125 P2860 Q91909125-DA66CEC0-AFEB-42FE-8B50-3469000C2B15 @default.
- Q91909125 P2860 Q91909125-E2708C40-6D75-4BD0-A9C7-BF40F9923E74 @default.
- Q91909125 P304 Q91909125-3B17E97E-9539-4796-A829-55EDA57A900B @default.
- Q91909125 P31 Q91909125-7B559A76-1DE3-4982-9F1E-23D6101A33FF @default.
- Q91909125 P31 Q91909125-de610dda-bf39-4c54-9440-45bdefa4b699 @default.
- Q91909125 P356 Q91909125-63BC1077-4BE8-4C08-B15D-D54A8C1B00DB @default.
- Q91909125 P433 Q91909125-22D5ED64-16D4-4051-8318-C4D6535F9B4F @default.
- Q91909125 P478 Q91909125-1EBAEC41-C0C2-40A8-9139-42CEB2629884 @default.
- Q91909125 P50 Q91909125-B27FE8ED-8868-49FB-B564-E3E4928FF31A @default.
- Q91909125 P577 Q91909125-9DB78A79-2009-4860-AD3A-3BCF414505EE @default.
- Q91909125 P6216 Q91909125-3718f341-6265-4f00-9a5b-18e2bdb9cbc8 @default.
- Q91909125 P698 Q91909125-53A6C598-3542-4C94-87DA-F6FF2A55AC22 @default.
- Q91909125 P921 Q91909125-089DD499-B12B-43B2-956B-044F088D8A2A @default.
- Q91909125 P921 Q91909125-29F28E01-2015-4957-82AD-6D30E35B1124 @default.
- Q91909125 P921 Q91909125-B4709645-F55C-4218-93C2-EC648206F8B5 @default.
- Q91909125 P932 Q91909125-E93C57F6-21C6-4E2C-BD2D-C73CF04A8B9A @default.
- Q91909125 P356 JGO.2019.30.E79 @default.
- Q91909125 P698 31074232 @default.
- Q91909125 P1433 Q26842232 @default.
- Q91909125 P1476 "The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia" @default.
- Q91909125 P275 Q34179348 @default.
- Q91909125 P2860 Q28083257 @default.
- Q91909125 P2860 Q33713863 @default.
- Q91909125 P2860 Q37833620 @default.
- Q91909125 P2860 Q38386687 @default.
- Q91909125 P2860 Q47273308 @default.
- Q91909125 P2860 Q50610816 @default.
- Q91909125 P2860 Q51036246 @default.
- Q91909125 P2860 Q51501652 @default.
- Q91909125 P2860 Q52886407 @default.
- Q91909125 P2860 Q61682690 @default.
- Q91909125 P2860 Q91909333 @default.
- Q91909125 P304 "e79" @default.
- Q91909125 P31 Q13442814 @default.
- Q91909125 P31 Q871232 @default.
- Q91909125 P356 "10.3802/JGO.2019.30.E79" @default.
- Q91909125 P433 "4" @default.
- Q91909125 P478 "30" @default.
- Q91909125 P50 Q91909121 @default.
- Q91909125 P577 "2019-04-01T00:00:00Z" @default.
- Q91909125 P6216 Q50423863 @default.
- Q91909125 P698 "31074232" @default.
- Q91909125 P921 Q1628262 @default.
- Q91909125 P921 Q416950 @default.
- Q91909125 P921 Q944777 @default.
- Q91909125 P932 "6543114" @default.